- Lilly CEO sees weight-loss drugs reaching about half of potential users at peak - Reuters Reuters —
- Eli Lilly's CEO is ‘disappointed’ that only 1 in 10 Americans are on GLP-1s Semafor —
- Lilly weight loss pill prescriptions said to near 1,400 in first week of launch Seeking Alpha —
- Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week - Reuters Reuters —
David A. Ricks
Pharmaceutical executive
David A. Ricks is an American businessman. He is currently the chair and chief executive officer of pharmaceutical company Eli Lilly and Company, assuming both roles in 2017. He is also a member of the board of directors of Adobe and the Purdue University Board of Trustees.
Also known as...
David Ricks and Dave Ricks
Lilly CEO Sees Massive GLP-1 Demand